Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucose-dependent insulin release from genetically engineered K cells.

A T Cheung1, B Dayanandan, J T Lewis

  • 1Department of Medicine, University of Alberta, Edmonton, AB T6G 2S2, Canada.

Science (New York, N.Y.)
|December 9, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vivo Image-Based 4D Modeling of Competent and Regurgitant Mitral Valve Dynamics.

Experimental mechanics·2021
Same author

Relationships between resilience and quality of life in parents of children with cancer.

Journal of health psychology·2021
Same author

Relationships among hope, psychological well-being and health-related quality of life in childhood cancer survivors.

Journal of health psychology·2019
Same author

Relationships among resilience, self-esteem, and depressive symptoms in Chinese adolescents.

Journal of health psychology·2018
Same author

Adventure-based training to promote physical activity and reduce fatigue among childhood cancer survivors: A randomized controlled trial.

International journal of nursing studies·2018
Same author

The importance of beta cell characterisation: generating human beta cells by differentiating human embryonic stem cells.

Diabetologia·2011

Scientists genetically engineered gut K cells to produce insulin, offering a potential new diabetes therapy. This approach successfully protected mice from diabetes by restoring glucose control after beta cell loss.

Area of Science:

  • Biotechnology
  • Endocrinology
  • Genetic Engineering

Background:

  • Diabetes mellitus is characterized by impaired insulin production or function.
  • Current therapies often require exogenous insulin administration.
  • Alternative strategies for endogenous insulin production are needed.

Purpose of the Study:

  • To investigate the potential of genetically engineering non-beta cells for insulin production.
  • To develop a novel therapeutic approach for diabetes using GIP-regulated insulin expression.

Main Methods:

  • Utilized a tumor-derived K-cell line for genetic modification.
  • Introduced the human insulin gene linked to the 5'-regulatory region of the glucose-dependent insulinotropic polypeptide (GIP) gene.
  • Assessed transgene expression and insulin production in mice.

Related Experiment Videos

Main Results:

  • Successfully induced human insulin production specifically in gut K cells of mice.
  • Transgenic mice were protected from developing chemically induced diabetes.
  • Glucose tolerance was maintained in mice even after destruction of native beta cells.

Conclusions:

  • Genetic engineering of gut K cells to produce insulin is a viable therapeutic strategy for diabetes.
  • GIP-regulated insulin expression in non-beta cells offers a potential alternative to traditional diabetes treatments.
  • This approach demonstrates the feasibility of restoring glucose homeostasis through engineered intestinal cells.